Bridgeway Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-32,000	Closed	-$614K	–	1451
2017 Q1	$614K	Buy	32,000 +5,000	+19%	+$95.9K	0.01%	992
2016 Q4	$450K	Hold	27,000	–	–	0.01%	1119
2016 Q3	$556K	Buy	+27,000	New	+$556K	0.01%	1043